FORE US Bio Inc. · CIK 1990659
FORE US Bio Inc.
Filings
2
Original notices
1
Amendments
1
Activity
May 15, 2025
through Jul 14, 2026
through Jul 14, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 15, 2025 · D | Jul 14, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $46,024,857 | $109,619,395 | $63,594,538 |
| Reported amount sold | $37,443,239 | $70,410,173 | $32,966,934 |
| Reported investor count | — | 20 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001990659-25-000002 · Later SEC source: 0001990659-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $109,619,395
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $70,410,173
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001990659-26-000001D/A · Jul 14, 2026 · BiotechnologyOffering: $109,619,395Sold: $70,410,173
Compared with 0001990659-25-000002:
- Reported offering amount: $46,024,857 → $109,619,395
- Reported amount sold: $37,443,239 → $70,410,173
- Reported investor count: Unavailable → 20
-
0001990659-25-000002D · May 15, 2025 · BiotechnologyOffering: $46,024,857Sold: $37,443,239